Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1 Study to Confirm the Single- and Multiple-dose Pharmacokinetics and to Evaluate Food Effect of Vapendavir in Healthy Participants and Participants With COPD

NCT05962645 is registered in ClinicalTrials.gov with Altesa Biosciences, Inc. as lead sponsor.

NCT NCT05962645
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05962645 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1 Study to Confirm the Single- and Multiple-dose Pharmacokinetics and to Evaluate Food Effect of Vapendavir in Healthy Participants and Participants With COPD
Lead sponsor
Altesa Biosciences, Inc.
Phase
Phase 1
Overall status
Completed
Start date
May 19, 2023
Completion date
May 2, 2024
Enrollment
21 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

copd, healthy, lower respiratory disease, pulmonary disease, respiratory disease